HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD53 antigen and epidermal growth factor induce similar changes in the pattern of phorbol ester binding in a B cell lymphoma.

Abstract
The CD53 antigen is a prototype member of the transmembrane-4 superfamily which includes several tumor antigens. In this report we have studied the changes in the cellular binding of phorbol esters after stimulation with monoclonal antibody (mAb) MRC OX-44 (anti-CD53) and epidermal growth factor (EGF) using a fluorochrome-phorbol ester binding assay. Incubation of a rat B cell lymphoma cell line with this mAb or EGF induces the appearance of high- and low-affinity phorbol ester binding sites and changes the total number of binding sites. Four binding sites with different characteristics have been detected. The binding data suggest that two structurally different receptors, CD53 antigen and EGF receptor, induce a similar change in the functional protein kinase C expressed in the cell which might be implicated in the responses elicited after cell stimulation.
AuthorsR Barcia, S García-Vargas, L Boscá, P A Lazo
JournalCellular immunology (Cell Immunol) Vol. 169 Issue 1 Pg. 107-12 (Apr 10 1996) ISSN: 0008-8749 [Print] Netherlands
PMID8612282 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • Cd53 protein, rat
  • Phorbol Esters
  • Tetraspanin 25
  • Epidermal Growth Factor
Topics
  • Animals
  • Antigens, CD (metabolism)
  • Antigens, Differentiation, T-Lymphocyte (metabolism)
  • Binding Sites
  • Epidermal Growth Factor (metabolism)
  • Lymphoma, B-Cell (metabolism)
  • Phorbol Esters (metabolism)
  • Rats
  • Signal Transduction
  • Tetraspanin 25
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: